ERBB2 and gastric cancer: However, they were not independent prognostic factors for OS as suggested by the multivariate analysis, which might be due to their tight relation with HER2 status, a very robust biomarker for targeted therapy efficacy and prognosis of GC as shown by previous research [6, 24].